Amrutanjan Health Care Limited · NSE: AMRUTANJAN · BSE: 590006
Amrutanjan Health Care
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 11 Aug 2026.
Q1 FY27 · Standalone
Revenue
102.97₹ Cr
+9.5% vs year ago
Net profit
4.37₹ Cr
−47.5% vs year ago
EPS, basic
1.51₹
−47.4% vs year ago
Net margin
4.2%
−4.6 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 102.97 | +9.5% | 4.37 | −47.5% | 1.51 | 11 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 149.77 | +10.6% | 16.19 | +6.7% | 5.60 | 08 May 2026 |
| Q3 FY26Oct–Dec 2025 | 141.04 | +14.9% | 19.45 | +1.1% | 6.73 | 03 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 117.70 | +7.1% | 13.96 | +18.4% | 4.83 | 10 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 94.05 | +12.3% | 8.31 | +80.1% | 2.87 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 135.41 | +6.6% | 15.18 | +11.1% | 5.25 | 23 Jun 2025 |
| Q3 FY25Oct–Dec 2024 | 122.75 | +4.9% | 19.25 | +10.3% | 6.66 | 12 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 109.92 | +10.7% | 11.80 | +72.2% | 4.08 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 83.74 | +7.5% | 4.62 | −34.2% | 1.60 | 27 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 127.06 | +26.7% | 13.66 | +7.6% | 4.72 | 13 Jun 2024 |
| Q3 FY24Oct–Dec 2023 | 116.99 | +19.8% | 17.45 | +62.9% | 6.05 | 22 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 99.31 | −10.3% | 6.85 | −46.3% | 2.36 | 23 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 77.86 | +9.7% | 7.01 | +91.5% | 2.40 | 02 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 100.32 | −5.9% | 12.70 | −13.7% | 4.35 | 31 May 2023 |
| Q3 FY23Oct–Dec 2022 | 97.65 | −11.8% | 10.71 | −48.0% | 3.67 | 17 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 110.72 | +0.3% | 12.77 | −35.7% | 4.37 | 17 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 70.95 | −9.3% | 3.66 | −69.6% | 1.25 | 06 Sep 2022 |
| Q4 FY22Jan–Mar 2022 | 106.55 | +13.3% | 14.71 | +43.8% | 5.09 | 03 Jun 2022 |
| Q3 FY22Oct–Dec 2021 | 110.70 | +10.6% | 20.58 | −1.9% | 7.05 | 12 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 110.38 | +19.8% | 19.85 | −15.7% | 6.79 | 09 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 78.21 | +67.8% | 12.06 | +87.6% | 4.12 | 17 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 94.02 | +58.6% | 10.23 | +29.6% | 3.50 | 28 May 2021 |
| Q3 FY21Oct–Dec 2020 | 100.10 | +21.0% | 20.99 | +121.1% | 7.18 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 92.11 | +23.1% | 23.55 | +180.2% | 8.06 | 16 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 46.62 | +4.5% | 6.43 | Turned profit | 2.20 | 13 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 59.29 | −31.0% | 7.89 | −44.7% | 2.70 | 18 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 82.75 | +17.8% | 9.49 | +79.6% | 3.25 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 74.82 | — | 8.40 | — | 2.87 | 11 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 44.60 | — | (0.70) | — | (0.24) | 14 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 85.97 | — | 14.27 | — | 4.88 | 28 May 2019 |
| Q3 FY19Oct–Dec 2018 | 70.27 | — | 5.29 | — | 1.81 | 12 Feb 2019 |
31 filings on record for this company.